Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

Breast cancer caregiving was the last thing on John K. Conner’s mind back in 1998. He and his wife, Anita T. Conner, were in ...

DOTHAN, Ala. (WDHN) — Law enforcement and biker clubs gathered on Saturday in Dothan to raise money for patrol officer ...

A subgroup analysis showed that the benefit in high-risk patients was limited to those with tumors >2 cm, reported Nan Chen, MD, of the University of Chicago, at the San Antonio Breast Cancer ...

Adding pembrolizumab to THP improved pCR rates in patients with HER2-positive breast cancer in the phase 2 NeoHIP trial.

Paclitaxel-based and nab-paclitaxel-based chemotherapy produced similar 5-year outcomes in patients with high-risk, HR+, HER2- early breast cancer.

According to real-world data, no survival advantage was seen when comparing 3 frontline CDK4/6 inhibitor combinations in ...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had better outcomes when ...

Nichole Andrews told Newsweek about a "sustainable, enjoyable, and scientifically supported for cancer risk reduction" diet.

A study presented at SABCS 2024 reveals that active monitoring provides similar quality-of-life outcomes as surgery for patients with low-risk DCIS.

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR ...

FILE - A radiologist uses a magnifying glass to check mammograms for breast cancer in Los Angeles, May 6, 2010. (AP ...